Featured Studies

Research Study 000444-H investigating how well the following vaccines work in patients with CLL/SLL malignancies: SHINGRIX and influenza vaccine. If you are currently receiving treatment for your CLL/SLL (e.g. ibrutinib, acalabrutinib or venetoclax), you may be able to participate.

Researchers at NIH are testing a new therapy in patients diagnosed with colitis due to chronic granulomatous disease (CGD). The research aims to see if restoring the gut microbiome reduces inflammation in the colon.

Research study #00-N-0082 aims to develop improved MRI techniques for studying brain function. Information obtained will be used to develop better imaging methods that will, in turn, permit a greater understanding of normal and abnormal brain behaviors.

The National Institutes on Alcohol Abuse and Alcoholism (NIAAA) is recruiting heavy drinkers for a study to evaluate the safety of an investigational drug to treat signs and symptoms of alcohol associated liver damage. If you drink more than 20 alcoholic beverages per week, you may have this type of liver damage.

Researchers at the National Institutes of Health (NIH) seek healthy volunteers to provide blood samples for research studies of blood vessels and immune diseases that cause clotting. In this study, investigators want to understand the basis of these diseases to facilitate the development of better treatments.

The National Institutes of Health (NIH) is conducting a research study of the causes and responses to treating multiple sclerosis (MS) and other brain and spine inflammatory conditions. Join this study if you have MS or a related disease. Although the study does not offer treatment options, your participation may help in future discoveries and inspire hope.